Cancer chemotherapy-induced osteoporosis: How common is it among Saudi Arabian cancer survivors

Indian Journal of Cancer

Volumn 46, Issue 4, 2009, Pages 331-334

  Amri, A ^a   Sadat, A ^a  

^a IMAM ABDULRAHMAN BIN FAISAL UNIVERSITY   (Saudi Arabia)

Author keywords

Cancer; Chemotherapy; Osteopenia; Osteoporosis

Indexed keywords

ANTINEOPLASTIC AGENT; CALCIUM; PHOSPHORUS;

ADULT; ARTICLE; BONE DENSITY; CALCIUM BLOOD LEVEL; CANCER CHEMOTHERAPY; CANCER SURVIVOR; CONTROLLED STUDY; HUMAN; MAJOR CLINICAL STUDY; OSTEOLYSIS; OSTEOPENIA; OSTEOPOROSIS; PHOSPHATE BLOOD LEVEL; PREVALENCE; SAUDI ARABIA; TREATMENT DURATION;

ABSORPTIOMETRY, PHOTON; ADULT; AGED; ANTINEOPLASTIC AGENTS; BONE DENSITY; FEMALE; HUMANS; MALE; MIDDLE AGED; NEOPLASMS; OSTEOPOROSIS; PREVALENCE; SAUDI ARABIA; SURVIVORS;

EID: 70349413203     PISSN: 0019509X     EISSN: 19984774     Source Type: Journal    
DOI: 10.4103/0019-509X.55554     Document Type: Article

References (18)

1. Painter SE, Kleerekoper M, Camacho PM. Secondary osteoporosis: a review of the recent evidence. Endocr Pract 2006;12:436-445
2. Hoff AO, Gagel RF. Osteoporosis in breast and prostate cancer survivors. Oncology (Williston Park) 2005;19:651-658
3. Cooper C. The crippling consequences of fractures and their impact on quality of life. Am J Med 1997;103:12S-17S.
4. Eastell R, Hannon RA, Cuzick J, Dowsett M, Clack G, Adams JE et al. Effect of anastrozole on bone density and bone turnover: results of the "Arimidex" (anastrozole), Tamoxifen. Alone or in combination (ATAC) trial. J Bone Miner Res 2006;21:1215-1223 (Pubitemid 44128334)
5. Shapiro CL, Manola J, Leboff M. Ovarian failure after adjuvant chemotherapy is associated with rapid bone loss in women with early-stage breast cancer. J Oncology 2001;19:3306-3311
6. Higano CS. Understanding treatments for bone loss and bone metastatses in patients with prostatic cancer: a practical review and guide for clinicians. Urol Clin North Am 2004;31:331-352
7. Headley JA, Theriault RL, LeBlanc AD, Vassilopoulou-Sellin R, Hortobagyi GN. Pilot study of bone mineral density in breast cancer patients treated with adjuvant chemotherapy. Cancer Invest 1998;16:6-11.
8. Lappe JM, Tinley ST. Prevention of osteoporosis in women treated for hereditary breast and ovarian carcinoma: a need that is overlooked. Cancer 1998;83:830-834
9. Mahon SM. Osteoporosis: A concern for cancer survivors. Oncol Nurs Forum 1998;25:843-851
10. SPSS, statistical software package, version 14.0. SPSS Inc. Chicago, Illinois, 2007.
11. Eid HS, Arteh SO. Cancer incidence report on Saudi Arabia 1999- 2000. Published by the main office, National Cancer Registry, under the Depository number at King Fahad National Library, 3480/22, date 6/9/1422H, ISSN:1658-0559, Riyadh May 2004, Page 22.
12. Guise TA. Bone loss and fracture risk associated with cancer therapy. Oncologist 2006;11:1121-1131
13. Twiss JJ, Waltman N, Ott CD, Gross GJ, Lindsey AM, Moore TE. Bone mineral density in postmenopausal breast cancer survivors. J Am Acad Nurse Pract 2001;13:276-284
14. Morris CA, Cabral D, Cheng H, Katz JN, Finkelstein JS, Avorn J, et al. Patterns of bone mineral density testing: current guidelines, testing rates, and Interventions. J Gen Intern Med 2004;19:783-790
15. Smith MD, Ross W, Ahern MJ. Missing a therapeutic window of opportunity: an audit of patients attending a tertiary teaching hospital with potentially osteoporotic hip and wrist fractures. J Rheumatol 2001;28:2504-2508
16. Waltman NL, Twiss JJ, Ott CD, Gross GJ, Lindsey AM, Moore TE, et al. Testing an intervention for preventing osteoporosis in postmenopausal breast cancer survivors. J Nurs Scholarsh 2003;4:333-338
17. Michaud LB, Goodin S. Cancer-treatment-induced bone loss part2. Amer J Health Syst Pharm 2006;63:534-546
18. King AB, Saag KG, Burge RT, Pisu M, Goel N. Fracture reduction effects Medicare economics (FRAME): impact of increased osteoporosis diagnosis and treatment. Osteoporosis Inter 2005;16:1545-1557